nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—ADRA1B—vas deferens—testicular cancer	0.205	0.618	CbGeAlD
Lisuride—HTR2A—vein—testicular cancer	0.0316	0.0954	CbGeAlD
Lisuride—Pulmonary fibrosis—Chlorambucil—testicular cancer	0.027	0.0404	CcSEcCtD
Lisuride—Pulmonary fibrosis—Bleomycin—testicular cancer	0.0209	0.0312	CcSEcCtD
Lisuride—Pericardial effusion—Ifosfamide—testicular cancer	0.0191	0.0286	CcSEcCtD
Lisuride—Pericarditis—Ifosfamide—testicular cancer	0.0182	0.0272	CcSEcCtD
Lisuride—Pulmonary fibrosis—Ifosfamide—testicular cancer	0.0179	0.0267	CcSEcCtD
Lisuride—Pleurisy—Methotrexate—testicular cancer	0.0152	0.0228	CcSEcCtD
Lisuride—DRD4—testis—testicular cancer	0.0149	0.045	CbGeAlD
Lisuride—Pulmonary fibrosis—Etoposide—testicular cancer	0.0141	0.0211	CcSEcCtD
Lisuride—DRD5—female gonad—testicular cancer	0.0111	0.0335	CbGeAlD
Lisuride—Aggression—Bleomycin—testicular cancer	0.0105	0.0156	CcSEcCtD
Lisuride—Pleural effusion—Ifosfamide—testicular cancer	0.0103	0.0153	CcSEcCtD
Lisuride—Dementia—Methotrexate—testicular cancer	0.00906	0.0135	CcSEcCtD
Lisuride—Pericardial effusion—Methotrexate—testicular cancer	0.00906	0.0135	CcSEcCtD
Lisuride—Pericarditis—Methotrexate—testicular cancer	0.00859	0.0128	CcSEcCtD
Lisuride—Pericardial effusion—Epirubicin—testicular cancer	0.00848	0.0127	CcSEcCtD
Lisuride—Pulmonary fibrosis—Methotrexate—testicular cancer	0.00845	0.0126	CcSEcCtD
Lisuride—ADRA2C—seminal vesicle—testicular cancer	0.00827	0.025	CbGeAlD
Lisuride—Infection—Carboplatin—testicular cancer	0.00818	0.0122	CcSEcCtD
Lisuride—Pericarditis—Epirubicin—testicular cancer	0.00804	0.012	CcSEcCtD
Lisuride—Pericardial effusion—Doxorubicin—testicular cancer	0.00784	0.0117	CcSEcCtD
Lisuride—Disorientation—Bleomycin—testicular cancer	0.00746	0.0111	CcSEcCtD
Lisuride—Pericarditis—Doxorubicin—testicular cancer	0.00744	0.0111	CcSEcCtD
Lisuride—ADRA2A—seminal vesicle—testicular cancer	0.0066	0.0199	CbGeAlD
Lisuride—Disorientation—Ifosfamide—testicular cancer	0.00637	0.00953	CcSEcCtD
Lisuride—HTR2A—embryo—testicular cancer	0.00598	0.0181	CbGeAlD
Lisuride—Hallucination—Chlorambucil—testicular cancer	0.00593	0.00887	CcSEcCtD
Lisuride—Weight decreased—Bleomycin—testicular cancer	0.00522	0.0078	CcSEcCtD
Lisuride—ADRA2C—female gonad—testicular cancer	0.00486	0.0147	CbGeAlD
Lisuride—Pleural effusion—Methotrexate—testicular cancer	0.00485	0.00725	CcSEcCtD
Lisuride—ADRA2A—gonad—testicular cancer	0.00477	0.0144	CbGeAlD
Lisuride—Dehydration—Cisplatin—testicular cancer	0.00457	0.00683	CcSEcCtD
Lisuride—Pleural effusion—Epirubicin—testicular cancer	0.00454	0.00679	CcSEcCtD
Lisuride—Orthostatic hypotension—Cisplatin—testicular cancer	0.00449	0.00671	CcSEcCtD
Lisuride—DRD2—testis—testicular cancer	0.00443	0.0134	CbGeAlD
Lisuride—ADRA2C—testis—testicular cancer	0.00431	0.013	CbGeAlD
Lisuride—Vertigo—Vinblastine—testicular cancer	0.00427	0.00639	CcSEcCtD
Lisuride—Confusional state—Chlorambucil—testicular cancer	0.00427	0.00639	CcSEcCtD
Lisuride—Infection—Chlorambucil—testicular cancer	0.00421	0.00629	CcSEcCtD
Lisuride—Pleural effusion—Doxorubicin—testicular cancer	0.0042	0.00628	CcSEcCtD
Lisuride—Abdominal discomfort—Cisplatin—testicular cancer	0.00407	0.00609	CcSEcCtD
Lisuride—HTR2A—gonad—testicular cancer	0.00406	0.0123	CbGeAlD
Lisuride—Anorexia—Chlorambucil—testicular cancer	0.00404	0.00604	CcSEcCtD
Lisuride—HTR2B—lymph node—testicular cancer	0.00397	0.012	CbGeAlD
Lisuride—Hallucination—Ifosfamide—testicular cancer	0.00393	0.00587	CcSEcCtD
Lisuride—ADRA2A—female gonad—testicular cancer	0.00388	0.0117	CbGeAlD
Lisuride—Anorexia—Vinblastine—testicular cancer	0.0037	0.00553	CcSEcCtD
Lisuride—Decreased appetite—Chlorambucil—testicular cancer	0.00368	0.00551	CcSEcCtD
Lisuride—Cardiac disorder—Ifosfamide—testicular cancer	0.00366	0.00547	CcSEcCtD
Lisuride—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00366	0.00547	CcSEcCtD
Lisuride—Fatigue—Chlorambucil—testicular cancer	0.00365	0.00546	CcSEcCtD
Lisuride—Angiopathy—Ifosfamide—testicular cancer	0.00358	0.00535	CcSEcCtD
Lisuride—Immune system disorder—Ifosfamide—testicular cancer	0.00356	0.00533	CcSEcCtD
Lisuride—Mediastinal disorder—Ifosfamide—testicular cancer	0.00356	0.00531	CcSEcCtD
Lisuride—Cough—Bleomycin—testicular cancer	0.00351	0.00524	CcSEcCtD
Lisuride—Feeling abnormal—Chlorambucil—testicular cancer	0.00349	0.00522	CcSEcCtD
Lisuride—Mental disorder—Ifosfamide—testicular cancer	0.00346	0.00517	CcSEcCtD
Lisuride—ADRA2A—testis—testicular cancer	0.00344	0.0104	CbGeAlD
Lisuride—Malnutrition—Ifosfamide—testicular cancer	0.00343	0.00513	CcSEcCtD
Lisuride—Decreased appetite—Vinblastine—testicular cancer	0.00338	0.00505	CcSEcCtD
Lisuride—Constipation—Vinblastine—testicular cancer	0.00332	0.00496	CcSEcCtD
Lisuride—Confusional state—Bleomycin—testicular cancer	0.00331	0.00494	CcSEcCtD
Lisuride—Infection—Bleomycin—testicular cancer	0.00326	0.00487	CcSEcCtD
Lisuride—Feeling abnormal—Vinblastine—testicular cancer	0.0032	0.00478	CcSEcCtD
Lisuride—Cardiac disorder—Cisplatin—testicular cancer	0.00316	0.00472	CcSEcCtD
Lisuride—Anorexia—Bleomycin—testicular cancer	0.00313	0.00467	CcSEcCtD
Lisuride—ADRA2C—lymph node—testicular cancer	0.00312	0.00944	CbGeAlD
Lisuride—Vertigo—Ifosfamide—testicular cancer	0.00309	0.00461	CcSEcCtD
Lisuride—Immune system disorder—Cisplatin—testicular cancer	0.00307	0.00459	CcSEcCtD
Lisuride—Mediastinal disorder—Cisplatin—testicular cancer	0.00307	0.00458	CcSEcCtD
Lisuride—Asthenia—Chlorambucil—testicular cancer	0.00304	0.00454	CcSEcCtD
Lisuride—Infection—Dactinomycin—testicular cancer	0.00304	0.00454	CcSEcCtD
Lisuride—Palpitations—Ifosfamide—testicular cancer	0.00303	0.00454	CcSEcCtD
Lisuride—CYP2D6—female gonad—testicular cancer	0.003	0.00907	CbGeAlD
Lisuride—Cough—Ifosfamide—testicular cancer	0.003	0.00448	CcSEcCtD
Lisuride—Malnutrition—Cisplatin—testicular cancer	0.00296	0.00443	CcSEcCtD
Lisuride—HTR2A—testis—testicular cancer	0.00292	0.00883	CbGeAlD
Lisuride—Dyspnoea—Bleomycin—testicular cancer	0.00292	0.00437	CcSEcCtD
Lisuride—Anorexia—Dactinomycin—testicular cancer	0.00292	0.00436	CcSEcCtD
Lisuride—Cardiac disorder—Etoposide—testicular cancer	0.00289	0.00432	CcSEcCtD
Lisuride—Decreased appetite—Bleomycin—testicular cancer	0.00285	0.00426	CcSEcCtD
Lisuride—Angiopathy—Etoposide—testicular cancer	0.00283	0.00423	CcSEcCtD
Lisuride—Confusional state—Ifosfamide—testicular cancer	0.00283	0.00422	CcSEcCtD
Lisuride—Immune system disorder—Etoposide—testicular cancer	0.00281	0.00421	CcSEcCtD
Lisuride—Mediastinal disorder—Etoposide—testicular cancer	0.00281	0.0042	CcSEcCtD
Lisuride—Asthenia—Vinblastine—testicular cancer	0.00279	0.00416	CcSEcCtD
Lisuride—Infection—Ifosfamide—testicular cancer	0.00278	0.00416	CcSEcCtD
Lisuride—Nervous system disorder—Ifosfamide—testicular cancer	0.00275	0.00411	CcSEcCtD
Lisuride—Hyperhidrosis—Ifosfamide—testicular cancer	0.00271	0.00405	CcSEcCtD
Lisuride—Feeling abnormal—Bleomycin—testicular cancer	0.0027	0.00404	CcSEcCtD
Lisuride—Vomiting—Chlorambucil—testicular cancer	0.00269	0.00403	CcSEcCtD
Lisuride—Anorexia—Ifosfamide—testicular cancer	0.00267	0.00399	CcSEcCtD
Lisuride—CYP2D6—testis—testicular cancer	0.00266	0.00805	CbGeAlD
Lisuride—Decreased appetite—Dactinomycin—testicular cancer	0.00266	0.00397	CcSEcCtD
Lisuride—Fatigue—Dactinomycin—testicular cancer	0.00264	0.00394	CcSEcCtD
Lisuride—Dizziness—Vinblastine—testicular cancer	0.00257	0.00384	CcSEcCtD
Lisuride—Feeling abnormal—Dactinomycin—testicular cancer	0.00252	0.00377	CcSEcCtD
Lisuride—Anxiety—Cisplatin—testicular cancer	0.00251	0.00375	CcSEcCtD
Lisuride—Dyspnoea—Ifosfamide—testicular cancer	0.0025	0.00374	CcSEcCtD
Lisuride—ADRA2A—lymph node—testicular cancer	0.00249	0.00753	CbGeAlD
Lisuride—Somnolence—Ifosfamide—testicular cancer	0.00249	0.00372	CcSEcCtD
Lisuride—Vomiting—Vinblastine—testicular cancer	0.00247	0.00369	CcSEcCtD
Lisuride—Vertigo—Etoposide—testicular cancer	0.00244	0.00364	CcSEcCtD
Lisuride—Decreased appetite—Ifosfamide—testicular cancer	0.00244	0.00364	CcSEcCtD
Lisuride—Headache—Vinblastine—testicular cancer	0.00243	0.00364	CcSEcCtD
Lisuride—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00242	0.00362	CcSEcCtD
Lisuride—Fatigue—Ifosfamide—testicular cancer	0.00242	0.00361	CcSEcCtD
Lisuride—Infection—Cisplatin—testicular cancer	0.0024	0.00359	CcSEcCtD
Lisuride—Constipation—Ifosfamide—testicular cancer	0.0024	0.00358	CcSEcCtD
Lisuride—Nervous system disorder—Cisplatin—testicular cancer	0.00237	0.00354	CcSEcCtD
Lisuride—Cough—Etoposide—testicular cancer	0.00237	0.00354	CcSEcCtD
Lisuride—Tachycardia—Cisplatin—testicular cancer	0.00236	0.00352	CcSEcCtD
Lisuride—Asthenia—Bleomycin—testicular cancer	0.00235	0.00352	CcSEcCtD
Lisuride—Dehydration—Epirubicin—testicular cancer	0.00235	0.00351	CcSEcCtD
Lisuride—Hyperhidrosis—Cisplatin—testicular cancer	0.00234	0.00349	CcSEcCtD
Lisuride—Feeling abnormal—Ifosfamide—testicular cancer	0.00231	0.00345	CcSEcCtD
Lisuride—Orthostatic hypotension—Epirubicin—testicular cancer	0.00231	0.00345	CcSEcCtD
Lisuride—Anorexia—Cisplatin—testicular cancer	0.0023	0.00344	CcSEcCtD
Lisuride—Abdominal discomfort—Methotrexate—testicular cancer	0.00224	0.00334	CcSEcCtD
Lisuride—Confusional state—Etoposide—testicular cancer	0.00223	0.00334	CcSEcCtD
Lisuride—Infection—Etoposide—testicular cancer	0.0022	0.00329	CcSEcCtD
Lisuride—Asthenia—Dactinomycin—testicular cancer	0.00219	0.00328	CcSEcCtD
Lisuride—Dehydration—Doxorubicin—testicular cancer	0.00217	0.00325	CcSEcCtD
Lisuride—Tachycardia—Etoposide—testicular cancer	0.00216	0.00323	CcSEcCtD
Lisuride—Dyspnoea—Cisplatin—testicular cancer	0.00215	0.00322	CcSEcCtD
Lisuride—Hyperhidrosis—Etoposide—testicular cancer	0.00214	0.0032	CcSEcCtD
Lisuride—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00213	0.00319	CcSEcCtD
Lisuride—Anorexia—Etoposide—testicular cancer	0.00211	0.00315	CcSEcCtD
Lisuride—Decreased appetite—Cisplatin—testicular cancer	0.0021	0.00314	CcSEcCtD
Lisuride—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00209	0.00312	CcSEcCtD
Lisuride—Vomiting—Bleomycin—testicular cancer	0.00209	0.00312	CcSEcCtD
Lisuride—Asthenia—Ifosfamide—testicular cancer	0.00201	0.00301	CcSEcCtD
Lisuride—Sweating—Methotrexate—testicular cancer	0.00199	0.00298	CcSEcCtD
Lisuride—Feeling abnormal—Cisplatin—testicular cancer	0.00199	0.00298	CcSEcCtD
Lisuride—Weight increased—Epirubicin—testicular cancer	0.00199	0.00297	CcSEcCtD
Lisuride—Weight decreased—Epirubicin—testicular cancer	0.00197	0.00295	CcSEcCtD
Lisuride—Dyspnoea—Etoposide—testicular cancer	0.00197	0.00295	CcSEcCtD
Lisuride—Somnolence—Etoposide—testicular cancer	0.00197	0.00294	CcSEcCtD
Lisuride—Vomiting—Dactinomycin—testicular cancer	0.00194	0.00291	CcSEcCtD
Lisuride—Decreased appetite—Etoposide—testicular cancer	0.00192	0.00288	CcSEcCtD
Lisuride—Gastrointestinal disorder—Etoposide—testicular cancer	0.00191	0.00286	CcSEcCtD
Lisuride—Fatigue—Etoposide—testicular cancer	0.00191	0.00285	CcSEcCtD
Lisuride—Constipation—Etoposide—testicular cancer	0.00189	0.00283	CcSEcCtD
Lisuride—Sweating—Epirubicin—testicular cancer	0.00187	0.00279	CcSEcCtD
Lisuride—Dizziness—Ifosfamide—testicular cancer	0.00185	0.00277	CcSEcCtD
Lisuride—Weight increased—Doxorubicin—testicular cancer	0.00184	0.00275	CcSEcCtD
Lisuride—Weight decreased—Doxorubicin—testicular cancer	0.00183	0.00273	CcSEcCtD
Lisuride—Feeling abnormal—Etoposide—testicular cancer	0.00182	0.00273	CcSEcCtD
Lisuride—Vomiting—Ifosfamide—testicular cancer	0.00178	0.00266	CcSEcCtD
Lisuride—Asthenia—Cisplatin—testicular cancer	0.00173	0.00259	CcSEcCtD
Lisuride—Cardiac disorder—Methotrexate—testicular cancer	0.00173	0.00259	CcSEcCtD
Lisuride—Sweating—Doxorubicin—testicular cancer	0.00173	0.00258	CcSEcCtD
Lisuride—Oedema peripheral—Epirubicin—testicular cancer	0.00172	0.00257	CcSEcCtD
Lisuride—Angiopathy—Methotrexate—testicular cancer	0.00169	0.00253	CcSEcCtD
Lisuride—Immune system disorder—Methotrexate—testicular cancer	0.00169	0.00252	CcSEcCtD
Lisuride—Mediastinal disorder—Methotrexate—testicular cancer	0.00168	0.00251	CcSEcCtD
Lisuride—Mental disorder—Methotrexate—testicular cancer	0.00164	0.00244	CcSEcCtD
Lisuride—Malnutrition—Methotrexate—testicular cancer	0.00162	0.00243	CcSEcCtD
Lisuride—Cardiac disorder—Epirubicin—testicular cancer	0.00162	0.00242	CcSEcCtD
Lisuride—Oedema peripheral—Doxorubicin—testicular cancer	0.00159	0.00238	CcSEcCtD
Lisuride—Asthenia—Etoposide—testicular cancer	0.00159	0.00237	CcSEcCtD
Lisuride—Angiopathy—Epirubicin—testicular cancer	0.00158	0.00237	CcSEcCtD
Lisuride—Immune system disorder—Epirubicin—testicular cancer	0.00158	0.00236	CcSEcCtD
Lisuride—Mediastinal disorder—Epirubicin—testicular cancer	0.00157	0.00235	CcSEcCtD
Lisuride—Vomiting—Cisplatin—testicular cancer	0.00154	0.0023	CcSEcCtD
Lisuride—Mental disorder—Epirubicin—testicular cancer	0.00153	0.00229	CcSEcCtD
Lisuride—Malnutrition—Epirubicin—testicular cancer	0.00152	0.00227	CcSEcCtD
Lisuride—Cardiac disorder—Doxorubicin—testicular cancer	0.0015	0.00224	CcSEcCtD
Lisuride—Angiopathy—Doxorubicin—testicular cancer	0.00147	0.00219	CcSEcCtD
Lisuride—Dizziness—Etoposide—testicular cancer	0.00146	0.00219	CcSEcCtD
Lisuride—Immune system disorder—Doxorubicin—testicular cancer	0.00146	0.00218	CcSEcCtD
Lisuride—Vertigo—Methotrexate—testicular cancer	0.00146	0.00218	CcSEcCtD
Lisuride—Mediastinal disorder—Doxorubicin—testicular cancer	0.00146	0.00218	CcSEcCtD
Lisuride—Cough—Methotrexate—testicular cancer	0.00142	0.00212	CcSEcCtD
Lisuride—Mental disorder—Doxorubicin—testicular cancer	0.00142	0.00212	CcSEcCtD
Lisuride—Vomiting—Etoposide—testicular cancer	0.00141	0.0021	CcSEcCtD
Lisuride—Malnutrition—Doxorubicin—testicular cancer	0.00141	0.0021	CcSEcCtD
Lisuride—Headache—Etoposide—testicular cancer	0.00139	0.00207	CcSEcCtD
Lisuride—Vertigo—Epirubicin—testicular cancer	0.00137	0.00204	CcSEcCtD
Lisuride—Syncope—Epirubicin—testicular cancer	0.00136	0.00204	CcSEcCtD
Lisuride—Palpitations—Epirubicin—testicular cancer	0.00134	0.00201	CcSEcCtD
Lisuride—Confusional state—Methotrexate—testicular cancer	0.00134	0.002	CcSEcCtD
Lisuride—Cough—Epirubicin—testicular cancer	0.00133	0.00198	CcSEcCtD
Lisuride—Infection—Methotrexate—testicular cancer	0.00132	0.00197	CcSEcCtD
Lisuride—Nervous system disorder—Methotrexate—testicular cancer	0.0013	0.00194	CcSEcCtD
Lisuride—Anxiety—Epirubicin—testicular cancer	0.00129	0.00193	CcSEcCtD
Lisuride—Hyperhidrosis—Methotrexate—testicular cancer	0.00128	0.00192	CcSEcCtD
Lisuride—Dry mouth—Epirubicin—testicular cancer	0.00127	0.00189	CcSEcCtD
Lisuride—Vertigo—Doxorubicin—testicular cancer	0.00126	0.00189	CcSEcCtD
Lisuride—Anorexia—Methotrexate—testicular cancer	0.00126	0.00189	CcSEcCtD
Lisuride—Syncope—Doxorubicin—testicular cancer	0.00126	0.00189	CcSEcCtD
Lisuride—Confusional state—Epirubicin—testicular cancer	0.00125	0.00187	CcSEcCtD
Lisuride—Palpitations—Doxorubicin—testicular cancer	0.00124	0.00186	CcSEcCtD
Lisuride—Infection—Epirubicin—testicular cancer	0.00123	0.00184	CcSEcCtD
Lisuride—Cough—Doxorubicin—testicular cancer	0.00123	0.00183	CcSEcCtD
Lisuride—Nervous system disorder—Epirubicin—testicular cancer	0.00122	0.00182	CcSEcCtD
Lisuride—Tachycardia—Epirubicin—testicular cancer	0.00121	0.00181	CcSEcCtD
Lisuride—Hyperhidrosis—Epirubicin—testicular cancer	0.0012	0.00179	CcSEcCtD
Lisuride—Insomnia—Methotrexate—testicular cancer	0.0012	0.00179	CcSEcCtD
Lisuride—Anxiety—Doxorubicin—testicular cancer	0.00119	0.00178	CcSEcCtD
Lisuride—Anorexia—Epirubicin—testicular cancer	0.00118	0.00177	CcSEcCtD
Lisuride—Dyspnoea—Methotrexate—testicular cancer	0.00118	0.00177	CcSEcCtD
Lisuride—Somnolence—Methotrexate—testicular cancer	0.00118	0.00176	CcSEcCtD
Lisuride—Dry mouth—Doxorubicin—testicular cancer	0.00117	0.00175	CcSEcCtD
Lisuride—Confusional state—Doxorubicin—testicular cancer	0.00116	0.00173	CcSEcCtD
Lisuride—Decreased appetite—Methotrexate—testicular cancer	0.00115	0.00172	CcSEcCtD
Lisuride—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00114	0.00171	CcSEcCtD
Lisuride—Fatigue—Methotrexate—testicular cancer	0.00114	0.00171	CcSEcCtD
Lisuride—Infection—Doxorubicin—testicular cancer	0.00114	0.0017	CcSEcCtD
Lisuride—Nervous system disorder—Doxorubicin—testicular cancer	0.00113	0.00168	CcSEcCtD
Lisuride—Insomnia—Epirubicin—testicular cancer	0.00112	0.00168	CcSEcCtD
Lisuride—Tachycardia—Doxorubicin—testicular cancer	0.00112	0.00167	CcSEcCtD
Lisuride—Hyperhidrosis—Doxorubicin—testicular cancer	0.00111	0.00166	CcSEcCtD
Lisuride—Dyspnoea—Epirubicin—testicular cancer	0.00111	0.00165	CcSEcCtD
Lisuride—Somnolence—Epirubicin—testicular cancer	0.0011	0.00165	CcSEcCtD
Lisuride—Anorexia—Doxorubicin—testicular cancer	0.00109	0.00164	CcSEcCtD
Lisuride—Feeling abnormal—Methotrexate—testicular cancer	0.00109	0.00163	CcSEcCtD
Lisuride—Decreased appetite—Epirubicin—testicular cancer	0.00108	0.00161	CcSEcCtD
Lisuride—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00107	0.0016	CcSEcCtD
Lisuride—Fatigue—Epirubicin—testicular cancer	0.00107	0.0016	CcSEcCtD
Lisuride—Constipation—Epirubicin—testicular cancer	0.00106	0.00159	CcSEcCtD
Lisuride—Insomnia—Doxorubicin—testicular cancer	0.00104	0.00155	CcSEcCtD
Lisuride—Dyspnoea—Doxorubicin—testicular cancer	0.00102	0.00153	CcSEcCtD
Lisuride—Feeling abnormal—Epirubicin—testicular cancer	0.00102	0.00153	CcSEcCtD
Lisuride—Somnolence—Doxorubicin—testicular cancer	0.00102	0.00153	CcSEcCtD
Lisuride—Decreased appetite—Doxorubicin—testicular cancer	0.000998	0.00149	CcSEcCtD
Lisuride—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000991	0.00148	CcSEcCtD
Lisuride—Fatigue—Doxorubicin—testicular cancer	0.00099	0.00148	CcSEcCtD
Lisuride—Constipation—Doxorubicin—testicular cancer	0.000982	0.00147	CcSEcCtD
Lisuride—Asthenia—Methotrexate—testicular cancer	0.000951	0.00142	CcSEcCtD
Lisuride—Feeling abnormal—Doxorubicin—testicular cancer	0.000946	0.00141	CcSEcCtD
Lisuride—Asthenia—Epirubicin—testicular cancer	0.00089	0.00133	CcSEcCtD
Lisuride—Dizziness—Methotrexate—testicular cancer	0.000877	0.00131	CcSEcCtD
Lisuride—Vomiting—Methotrexate—testicular cancer	0.000843	0.00126	CcSEcCtD
Lisuride—Headache—Methotrexate—testicular cancer	0.000831	0.00124	CcSEcCtD
Lisuride—Asthenia—Doxorubicin—testicular cancer	0.000824	0.00123	CcSEcCtD
Lisuride—Dizziness—Epirubicin—testicular cancer	0.000821	0.00123	CcSEcCtD
Lisuride—Vomiting—Epirubicin—testicular cancer	0.000789	0.00118	CcSEcCtD
Lisuride—Headache—Epirubicin—testicular cancer	0.000777	0.00116	CcSEcCtD
Lisuride—Dizziness—Doxorubicin—testicular cancer	0.000759	0.00113	CcSEcCtD
Lisuride—Vomiting—Doxorubicin—testicular cancer	0.00073	0.00109	CcSEcCtD
Lisuride—Headache—Doxorubicin—testicular cancer	0.000719	0.00108	CcSEcCtD
